News
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...
Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas ...
Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
President Donald Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month and that levies on semiconductors could come soon as well, suggesting that those import ...
In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Tariffs on medications and raw ingredients impact global drug prices - hurting consumers and adding pressure to the healthcare system.
Trump’s latest two industrial sector tariffs—200 percent on pharmaceuticals and 50 percent on copper—have serious ...
At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results